Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07040332

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Qianfoshan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2025-05-10
Primary completion
2027-07-31
Completion
2029-01-31
First posted
2025-06-27
Last updated
2025-07-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07040332. Inclusion in this directory is not an endorsement.

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis (NCT07040332) · Clinical Trials Directory